Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Innovation Pharmaceuticals Inc. | Financial_Report.xls |
| 10-Q - FORM 10Q QUARTERLY REPORT - Innovation Pharmaceuticals Inc. | Sept2012_10q.htm |
| EX-31 - EXHIBIT 31-1 - Innovation Pharmaceuticals Inc. | quarterly_ex31z1.htm |
Exhibit 32-1
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Leo Ehrlich, Interim Chief Executive Officer and Chief Financial Officer of Cellceutix Corporation, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:
|
| (1) the Quarterly Report on Form 10-Q of Cellceutix Corporation for the quarter ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
|
| (2) the information contained in the such Quarterly Report on Form 10-Q of Cellceutix Corporation for the quarter ended September 30, 2012 fairly presents, in all material respects, the financial condition and results of operations of Cellceutix Corporation. |
|
|
|
|
|
| CELLCEUTIX CORPORATION | |
|
|
|
|
| Date: November 19, 2012 | By: | /s/ Leo Ehrlich |
|
| Leo Ehrlich | |
|
| Chief Executive Officer, Chief Financial Officer (Principal Executive, Accounting and Financial Officer)
| |
|
| Chairman of the Board of Directors | |